MyChesCo on MSN7d
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
Medical Dialogues2d
Keep strict vigilance on banned chloramphenicol and nitrofurans formulations: CDSCO tells state and UT drug controllers
In line with the ban of drug formulations containing chloramphenicol and nitrofurans for use in any food-producing animal ...
pharmaphorum11d
GSK ends decades-long hiatus in oral antibiotics for UTIs
The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary ...
Medindia4d
Blujepa: First New Oral UTI Antibiotic in 30 Years
Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...
PharmExec11d
FDA Approves GSK’s Blujepa for Uncomplicated Urinary Tract Infections
Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...
Fierce Pharma12d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Contract Pharma11d
GSK’s Blujepa Approved by FDA for Treatment of uUTIs
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
Medical Dialogues12d
FDA Approves Gepotidacin for Uncomplicated UTIs
The FDA has approved GSK’s gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged ...